Although the mechanisms that underlie increased susceptibility to cancer in individuals with type II diabetes or obesity remain largely unknown, several concepts are beginning to emerge through the study of mouse models that combine cancer with a model of obesity/ type II diabetes (generated by a genetically engineered deletion of the Insulin Growth factor 1 (IGF1)) [46,47]. The gene discussed is IGF1; the disease is cancer.